HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elizabeth Escobar-Arriaga Selected Research

Therapeutics

10/2013Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elizabeth Escobar-Arriaga Research Topics

Disease

3Breast Neoplasms (Breast Cancer)
07/2019 - 10/2013
2Neoplasms (Cancer)
01/2016 - 10/2013
1Carcinoma (Carcinomatosis)
07/2019
1Neoplasm Metastasis (Metastasis)
07/2019
1Meningioma (Meningiomas)
07/2010

Drug/Important Bio-Agent (IBA)

2Phosphotransferases (Kinase)IBA
01/2016 - 10/2013
1CytokinesIBA
07/2019
1Gentian Violet (Violet, Crystal)FDA Link
07/2019
1Metformin (Glucophage)FDA LinkGeneric
07/2019
1VimentinIBA
07/2019
1Cadherins (E-Cadherin)IBA
07/2019
1Interleukin-6 (Interleukin 6)IBA
07/2019
1Tyrosine Kinase InhibitorsIBA
01/2016
1tyrosine receptor (receptor, tyrosine)IBA
01/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2013
1Tyrosine (L-Tyrosine)FDA Link
10/2013
1Imatinib Mesylate (Gleevec)FDA Link
10/2013
1Transcription Factors (Transcription Factor)IBA
10/2013
1Progesterone Receptors (Progesterone Receptor)IBA
07/2010
1Estrogens (Estrogen)FDA Link
07/2010

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2016
1Therapeutics
10/2013